Strata Critical Medical (NASDAQ:SRTA) Earns Buy Rating from Analysts at Craig Hallum

Craig Hallum started coverage on shares of Strata Critical Medical (NASDAQ:SRTA) in a research report sent to investors on Wednesday morning, Marketbeat Ratings reports. The firm issued a buy rating and a $8.00 price target on the stock.

Separately, B. Riley Financial assumed coverage on shares of Strata Critical Medical in a report on Wednesday. They issued a “buy” rating and a $8.00 price objective on the stock. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus target price of $8.00.

Strata Critical Medical Stock Performance

Shares of NASDAQ:SRTA opened at $4.14 on Wednesday. Strata Critical Medical has a one year low of $2.35 and a one year high of $6.02.

Strata Critical Medical Company Profile

Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.